SNPMiner Trials by Shray Alag

SNPMiner SNPMiner Trials (Home Page)

Report for Clinical Trial NCT03523052

Developed by Shray Alag, 2020.
SNP Clinical Trial Gene

The Chinese Parkinson's Disease With SNCA Variants Registry

The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.

NCT03523052 Parki Parkinson Disease
MeSH:Parkinson Disease

Primary Outcomes

Description: Establish the database of Parkinson's disease with SNCA variants in mainland China.

Measure: Database of Parkinson's disease with SNCA variants

Time: 10 years

Description: Characterize the clinical feature in patients of Parkinson's disease with SNCA variants

Measure: Clinical feature

Time: 10 years
Time Perspective: Prospective

Cohort

There are 2 SNPs

SNPs

1 rs11931074

However, some polymorphisms of SNCA gene such as rs894278 and rs11931074 can affect the risk of sporadic PD.

2 rs894278

However, some polymorphisms of SNCA gene such as rs894278 and rs11931074 can affect the risk of sporadic PD.


HPO Nodes